Regulation of estrogen receptors α and β in human breast carcinoma by exogenous leptin in nude mouse xenograft model

Chinese Medical Journal

Volumn 123, Issue 3, 2010, Pages 337-343

  Yu, Wei ^a   Gu, Jun Chao ^a   Liu, Jian Zhong ^a   Wang, Shao Hong ^a   Wang, Yu ^a   Zhang, Zhong Tao ^a   Ma, Xue Mei ^a   Song, Mao Min ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Estrogen receptors and ; Human leptin; Xenograft model

Indexed keywords

COMPLEMENTARY DNA; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MESSENGER RNA; RECOMBINANT LEPTIN; SINGLE STRANDED DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER GRAFT; CANCER MODEL; CANCER TISSUE; CELL STRAIN MCF 7; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; DRUG SAFETY; DRUG TARGETING; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; UPREGULATION; WESTERN BLOTTING; XENOGRAFT;

ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEPTIN; MICE; MICE, NUDE; POLYMERASE CHAIN REACTION; RANDOM ALLOCATION; RNA, MESSENGER; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 76649129882     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.03.015     Document Type: Article

References (26)

1. Catalano S, Mauro L, Marsico S, Giordano C, Rizza P, Rago V, et al. Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells. Biol Chem 2004; 279: 19908-19915.
2. Wang SH, Ma XM, Gu JC, Zhang ZT, WangY. Effects of leptin on breast cancer MCF-7 cells proliferation in vitro by regulation of estrogen receptor and VEGF. Chin J Cancer Prev Treatment (Chin) 2007; 14: 1857-1859.
3. Rose DP, Gilhooly EM, Nixon DW. Adverse effects of obesity on breast cancer prognosis,and the biological actions of leptin. Int J Oncol 2002; 21: 1285-1292.
4. Harvie MN, Bokhari S, Shenton A, Ashcroft L, Evans G, Swindell R, et al. Adult weight gain and central obesity in women with and without a family history of breast cancer: a case control study. Fam Cancer 2007; 6: 287-294.
5. Ozet A, Arpaci F, Yilmaz MI, Ayta H, Ozturk B, Komurcu S, et al. Efects of tamoxifen on the serum leptin level in patients with breast cancer. J Clin Onco1 2001; 31: 424-427.
6. Tessitore L, Vizio B, Jenkins O, De Stefano I, Ritossa C, Argiles JM, et al. Leptin expression in colorectal and breast cancer patients. Int J Mol Med 2000; 5: 421-426.
7. Saxena NK, Vertino PM, Anania FA, Sharma D. leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3. J Biol Chem 2007; 282: 13316-13325.
8. Garofalo C, Koda M, Cascio S, Sulkowska M, Kanczuga-Koda L, Golaszewska J, et al. Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clin Cancer Res 2006; 12: 1447-1453.
9. Okumura M, Yamamoto M, Sakuma H, Kojima T, Maruyama T, Jamali M, et al. Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: reciprocal involvement of PKC-alpha and PPAR expression. Biochim Biophys Acta 2002; 1592: 107-116.
10. Meli R, Pacilio M, Raso GM, Esposito E, Coppola A, Nasti A, et al. Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats. Endocrinology 2004; 145: 3115-3121.
11. Wang S, Wang S, Zhang JQ, Qiao XM, Yang DQ, Tong FZ, et al. Expression and signif icance of estrogen receptor isoforms in the development of human breast carcinoma. Chin J Surg (Chin) 2004; 42: 792-794.
12. Hirosawa M, Minata M, Harada KH, Hitomi T, Krust A, Koizumi A. Ablation of estrogen receptor alpha (ERalpha) prevents upregulation of POMC by leptin and insulin. Biochem Biophys Res Commun 2008; 371: 320-323.
13. Ray A, Nkhata KJ, Cleary MP. Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status. Int J Oncol 2007; 30: 1499-1509.
14. Li L, Sacks DB. Functional interactions between calmodulin and estrogen receptor-alpha. Cell Signal 2007; 19: 439-443.
15. Iwase H, Zhang Z, Omoto Y, Sugiura H, Yamashita H, Toyama T, et al. Clinical significance of the expression of estrogen receptors alpha and beta for endocrine therapy of breast cancer. Cancer Chemother Pharmacol 2003; 52 Suppl 1: s34-s38.
16. Cirillo D, Rachiglio AM, la Montagna R, Giordano A, Normanno N. Leptin signaling in breast cancer: an overview. J Cell Biochem 2008; 105: 956-964.
17. Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Cancer Res 2002; 62: 4977-4984.
18. Hartman J, Lindberg K, Morani A, Inzunza J, Ström A, Gustafsson JA. Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts. Cancer Res 2006; 66: 11207-11213.
19. Speirs V, Kerin MJ. Prognostic significance of estrogen receptor beta in breast cancer. Br J Surg 2000; 87: 405-409.
20. Harris HA, Bruner-Tran KL, Zhang X, Osteen KG, Lyttle CR. A selective estrogen receptor-beta agonist causes lesion regression in an experimentally induced model of endometriosis. Hum Reprod 2005; 20: 936-941.
21. Paruthiyil S, Parmar H, Kerekatte V, Cunha GR, Firestone GL, Leitman DC. Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res 2004; 64: 423-428.
22. Zagouri F, Sergentanis TN, Zografos GC. Precursors and preinvasive lesions of the breast: the role of molecular prognostic markers in the diagnostic and therapeutic dilemma. World J Surg Oncol 2007; 5: 57.
23. Saville B, Wormke M, Wang F, Nguyen T, Enmark E, Kuiper G, et al. Ligand-, cell-, and estrogen receptor subtype (α/β)-dependent activation at GC-rich (Sp1) promoter elements. J Biol Chem 2000; 275: 5379-5387.
24. Wada-Hiraike O, Hiraike H, Okinaga H, Imamov O, Barros RP, Morani A, et al. Role of estrogen receptor beta in uterine stroma and epithelium: insights from estrogen receptor beta-/-mice. Proc Natl Acad Sci U S A 2006; 103: 18350-18355.
25. Shaaban AM, O'Neill PA, Davies MP, Sibson R, West CR, Smith PH, et al. Declining estrogen receptor-beta expression defines malignant progression of human breast neoplasia. Am J Surg Pathol 2003; 27: 1502-1512.
26. Shaaban AM, Jarvis C, Moore F, West C, Dodson A, Foster CS. Prognostic significance of estrogen receptor beta in epithelial hyperplasia of usual type with known outcome. Am J Surg Pathol 2005; 29: 1593-1599.